Back to News
Market Impact: 0.15
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
Source: zacks.com
Healthcare & BiotechAnalyst EstimatesAnalyst Insights
Four biotech stocks, including TG Therapeutics and Immunome, have positive Earnings ESPs and favorable Zacks Ranks, which Zacks identifies as indicators of potential third-quarter earnings beats. The article gives no specific earnings forecasts or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
IMNM0.35
TGTX0.35
More News
- Up 37% since March - this AI-picked IT services stock keeps climbing
- We're cutting our Qnity price target but still loved the beat-and-raise quarter
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock
- Defense stocks slide on fear Democrats will curb spending. One analyst say it's a buying opportunity
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate